Sensors of ionizing radiation effects on the immunological microenvironment of cancer

Purpose: When cancer develops in an immunocompetent host it represents the result of a successful deception of the immune system as to the nature of the danger and the type of response needed to reject the neoplastic tissue. We will briefly review some of the recently emerged evidence that irradiation of the tumor and its microenvironment can induce essential molecular signals required for an effective response of the immune system to the tumor. Conclusions: The subversion of a highly organized tissue architecture is a hallmark of cancer, and results in uneven distribution of oxygen and nutrients, interstitial pressure gradients and areas of patchy necrosis and inflammation. In this microenvironment, cancer cells that carry mutations favoring survival rather than cell death in response to stress find a selection advantage. Importantly, the signals derived from the disruption of orderly physiology within tissues are also what the immune system has evolved to respond to. The type of response is tuned to be adequate to the cause of the disruption. An infectious organism will carry or elicit from the involved tissue a number of ‘danger signals’ leading to development of cell mediated and humoral responses to both eliminating the invader and preventing future infections. In contrast, a simple wound will call for a repair response. The sensors of the type of damage are complex molecular interactions between the damaged organ and cells of the innate and adaptive immune system. Progress in the identification of these interactions elucidates which pathways are specifically altered in cancer. It also provides a novel understanding of the radiation-induced effects on tumor immunogenicity. We propose that specific radiation-induced effects could be successfully exploited to improve the effectiveness of immunotherapy.

[1]  R. Weichselbaum,et al.  Induced sensitization of tumor stroma leads to eradication of established cancer by T cells , 2007, The Journal of experimental medicine.

[2]  C. Blank,et al.  Immune resistance orchestrated by the tumor microenvironment , 2006, Immunological reviews.

[3]  Z. Trajanoski,et al.  Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome , 2006, Science.

[4]  N. Kawashima,et al.  The Combination of Ionizing Radiation and Peripheral Vaccination Produces Long-term Survival of Mice Bearing Established Invasive GL261 Gliomas , 2006, Clinical Cancer Research.

[5]  K. Camphausen,et al.  Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy , 2006, The Journal of experimental medicine.

[6]  I. Lax,et al.  Regression of non-irradiated metastases after extracranial stereotactic radiotherapy in metastatic renal cell carcinoma , 2006, Acta oncologica.

[7]  Mary Helen Barcellos-Hoff,et al.  Radiation and the microenvironment – tumorigenesis and therapy , 2005, Nature Reviews Cancer.

[8]  Robert C. Rose,et al.  Local Radiation Therapy of B16 Melanoma Tumors Increases the Generation of Tumor Antigen-Specific Effector Cells That Traffic to the Tumor1 , 2005, The Journal of Immunology.

[9]  Youjin Lee,et al.  Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors , 2005, The Journal of experimental medicine.

[10]  S. Demaria,et al.  Select forms of tumor cell apoptosis induce dendritic cell maturation , 2005, Journal of leukocyte biology.

[11]  S. Demaria,et al.  Downregulation of major histocompatibility complex antigens in invading glioma cells: stealth invasion of the brain , 2005, Laboratory Investigation.

[12]  N. Kawashima,et al.  Immune-mediated inhibition of metastases after treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[13]  J. Schlom,et al.  Sublethal Irradiation of Human Tumor Cells Modulates Phenotype Resulting in Enhanced Killing by Cytotoxic T Lymphocytes , 2004, Cancer Research.

[14]  S. Adams,et al.  Manipulating dendritic cell biology for the active immunotherapy of cancer. , 2004, Blood.

[15]  George Coukos,et al.  Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival , 2004, Nature Medicine.

[16]  Nina Bhardwaj,et al.  Danger signals: a time and space continuum. , 2004, Trends in molecular medicine.

[17]  Sun-Hee Kim,et al.  Direct injection of immature dendritic cells into irradiated tumor induces efficient antitumor immunity , 2004, International journal of cancer.

[18]  N. Kawashima,et al.  Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated. , 2004, International journal of radiation oncology, biology, physics.

[19]  S. Cingarlini,et al.  Derangement of immune responses by myeloid suppressor cells , 2004, Cancer Immunology, Immunotherapy.

[20]  Fumito Ito,et al.  Radiotherapy potentiates the therapeutic efficacy of intratumoral dendritic cell administration. , 2003, Cancer research.

[21]  S. Evans,et al.  Tumor microvasculature as a barrier to antitumor immunity , 2003, Cancer Immunology, Immunotherapy.

[22]  C. N. Coleman,et al.  Irradiation of Tumor Cells Up-Regulates Fas and Enhances CTL Lytic Activity and CTL Adoptive Immunotherapy , 2003, The Journal of Immunology.

[23]  R. Schreiber,et al.  Cancer immunoediting: from immunosurveillance to tumor escape , 2002, Nature Immunology.

[24]  Michael S. Kuhns,et al.  CTLA-4: new insights into its biological function and use in tumor immunotherapy , 2002, Nature Immunology.

[25]  D. Gabrilovich,et al.  Immature myeloid cells and cancer-associated immune suppression , 2002, Cancer Immunology, Immunotherapy.

[26]  G. Hämmerling,et al.  Combination of T-cell therapy and trigger of inflammation induces remodeling of the vasculature and tumor eradication. , 2002, Cancer research.

[27]  D. Gabrilovich,et al.  Combination of γ‐irradiation and dendritic cell administration induces a potent antitumor response in tumor‐bearing mice: Approach to treatment of advanced stage cancer , 2001, International journal of cancer.

[28]  T. Carlos Leukocyte recruitment at sites of tumor: dissonant orchestration , 2001, Journal of leukocyte biology.

[29]  R. Schreiber,et al.  IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity , 2001, Nature.

[30]  J. Trapani,et al.  A fresh look at tumor immunosurveillance and immunotherapy , 2001, Nature Immunology.

[31]  N. Bhardwaj,et al.  Dendritic cells resurrect antigens from dead cells. , 2001, Trends in immunology.

[32]  A. Bendelac,et al.  CD1d-restricted mouse Vα14 and human Vα24 T cells: lymphocytes of innate immunity , 2000 .

[33]  M. Lotze,et al.  The dendritic cell and human cancer vaccines. , 2000, Current opinion in immunology.

[34]  Nina Bhardwaj,et al.  Consequences of cell death: exposure to necrotic tumor cells , 2000 .

[35]  B. Vikram,et al.  Flt3-ligand administration after radiation therapy prolongs survival in a murine model of metastatic lung cancer. , 1999, Cancer research.

[36]  J. Shimizu,et al.  Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity. , 1999, Journal of immunology.

[37]  D. Hallahan,et al.  Accumulation of P-selectin in the lumen of irradiated blood vessels. , 1999, Radiation research.

[38]  J. Hong,et al.  Effects of IL-3 gene expression on tumor response to irradiation in vitro and in vivo. , 1997, Cancer research.

[39]  J. Bertho,et al.  Late and persistent up-regulation of intercellular adhesion molecule-1 (ICAM-1) expression by ionizing radiation in human endothelial cells in vitro. , 1997, International journal of radiation biology.

[40]  F. Sallusto,et al.  Origin, maturation and antigen presenting function of dendritic cells. , 1997, Current opinion in immunology.

[41]  D. Hallahan,et al.  Cell adhesion molecules mediate radiation-induced leukocyte adhesion to the vascular endothelium. , 1996, Cancer research.

[42]  D. Carbone,et al.  Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells , 1996, Nature Medicine.

[43]  K. Imai,et al.  Effect of radiation on the expression of carcinoembryonic antigen of human gastric adenocarcinoma cells , 1991, Cancer.

[44]  Cellular and Humoral Aspects of the Hypersensitive States , 1959, Pediatrics.

[45]  M BURNET,et al.  Cancer—A Biological Approach* , 1957, British medical journal.

[46]  L. Zitvogel,et al.  Calreticulin exposure dictates the immunogenicity of cancer cell death , 2007, Nature Medicine.

[47]  L. Milas,et al.  Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances tumor response to fractionated radiotherapy. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[48]  M J Bissell,et al.  Microenvironmental Regulators of Tissue Structure and Function Also Regulate Tumor Induction and Progression : The Role of Extracellular Matrix and Its Degrading Enzymes , 2022 .

[49]  Hua Yu,et al.  Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells , 2004, Nature Medicine.

[50]  F. Marincola,et al.  Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance. , 2000, Advances in immunology.

[51]  A. Bendelac,et al.  CD1d-restricted mouse V alpha 14 and human V alpha 24 T cells: lymphocytes of innate immunity. , 2000, Seminars in immunology.

[52]  A. Goldberg,et al.  Degradation of cell proteins and the generation of MHC class I-presented peptides. , 1999, Annual review of immunology.

[53]  R K Jain,et al.  Transport of molecules, particles, and cells in solid tumors. , 1999, Annual review of biomedical engineering.

[54]  J. Booker,et al.  Discussion-•-— »-— — — — — , 1998 .

[55]  P. Matzinger Tolerance, danger, and the extended family. , 1994, Annual review of immunology.

[56]  C. Melief,et al.  Tumor eradication by adoptive transfer of cytotoxic T lymphocytes. , 1992, Advances in cancer research.

[57]  H. Lawrence Cellular and humoral aspects of the hypersensitive states : a symposium held at the New York academy of medicine , 1959 .

[58]  E. Blundi [Metastatic lung cancer]. , 1953, Revista brasileira de tuberculose e doencas toracicas.